Feladilimab
Product Specifications
CAS Number
2252518-85-5
Target
PD-1/PD-L1|||COX
Related Pathways
Cell Cycle/Checkpoint|||Immunology/Inflammation|||Neuroscience|||Apoptosis
Purity
0.9794
Bioactivity
Feladilimab (GSK3359609) is an IgG4 monoclonal antibody that is an ICOS agonist. Feladilimab binds to ICOS-expressing T cells, induces IFN?, and increases PD-1/L1 expression. Feladilimab has anti-tumor activity and can be used to study cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1282938-01 0.02 mg (E-Coli)
Recombinant Dictyostelium discoideum Probable phosphoserine aminotransferase (serC)
Ask
View Details MBS1282938-02 0.02 mg (Yeast)
Recombinant Dictyostelium discoideum Probable phosphoserine aminotransferase (serC)
Ask
View Details MBS1282938-03 0.1 mg (E-Coli)
Recombinant Dictyostelium discoideum Probable phosphoserine aminotransferase (serC)
Ask
View Details MBS1282938-04 0.1 mg (Yeast)
Recombinant Dictyostelium discoideum Probable phosphoserine aminotransferase (serC)
Ask
View Details